Related News
Home 禄 Metro 禄 Health and Science
Tonic companies face FDA action
THE Shanghai Food and Drug Administration yesterday reported two tonics detected with illegal chemical compounds and another using a competitor's product license to cheat the public.
Two production batches of a prostate tonic made by the Beijing Cidejindian Biological Technology Co were found to have chemicals used in licensed medicines.
The Bainiantong Capsule produced on March 5 by the Qinghai Bainiantang Health Tonics Co contained five chemicals used in painkillers or anti-inflammatories.
The tonic was badged as a rheumatism treatment.
Health tonics must receive a license from the Ministry of Health or the State Food and Drug Administration and certain medical ingredients must not be used.
The Baixing Capsule, whose maker was not named, was found using the license of another tonic. This capsule was sold as a diabetes tonic.
Shanghai FDA will proceed with disciplinary action.
Two production batches of a prostate tonic made by the Beijing Cidejindian Biological Technology Co were found to have chemicals used in licensed medicines.
The Bainiantong Capsule produced on March 5 by the Qinghai Bainiantang Health Tonics Co contained five chemicals used in painkillers or anti-inflammatories.
The tonic was badged as a rheumatism treatment.
Health tonics must receive a license from the Ministry of Health or the State Food and Drug Administration and certain medical ingredients must not be used.
The Baixing Capsule, whose maker was not named, was found using the license of another tonic. This capsule was sold as a diabetes tonic.
Shanghai FDA will proceed with disciplinary action.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔$粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.